Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015
Background: Stereotactic body radiotherapy (SABR) plays an essential role in the curative treatment of early-stage lung cancer. Second primary malignancy (SPM) has become a significant concern in lung cancer management because of the increasing number of cancer survivors. However, whether SABR incre...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2026-01-01
|
| Schriftenreihe: | Cancer Treatment and Research Communications |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S246829422600122X |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
